Cargando…
Increased cutaneous squamous cell carcinoma risk with hydrochlorothiazide use: is there a safe alternative?
Linked Article: Schneider et al. Br J Dermatol 2021; 185:343–352.
Autores principales: | Hollestein, L.M., Arnspang Pedersen, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457169/ https://www.ncbi.nlm.nih.gov/pubmed/34224145 http://dx.doi.org/10.1111/bjd.20526 |
Ejemplares similares
-
Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma
por: Pottegård, Anton, et al.
Publicado: (2018) -
Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study
por: Pottegård, Anton, et al.
Publicado: (2019) -
Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data
por: Venables, Zoe Claire, et al.
Publicado: (2022) -
Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study
por: Venables, Z.C., et al.
Publicado: (2019) -
Telmisartan/hydrochlorothiazide: Nevus-associated cutaneous melanoma: case report
Publicado: (2021)